Speedus Stock

Speedus Receivables

The Accounts Receivable of Speedus (SPDE) as of Aug 5, 2026 is 55,000.00 USD.

Receivables

55,000.00USD

Last updated:

Accounts Receivable of Speedus is 2026 55,000.00 USD. Accounts Receivable of Speedus was 2025 - USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Speedus Stock analysis

What does Speedus do? Speedus Corp is a US-American company that was founded in 1998 and has its headquarters in Philadelphia. The company specializes in medical services, including the delivery of medical samples, preparations, and instruments. The company is divided into three divisions: Speedus, RTI, and Shamrock. Speedus offers courier services for the medical field, allowing customers to enter their requirements through an online platform or over the phone. This ensures that orders are processed quickly and reliably. The RTI division of Speedus specializes in clinical research and development. They offer consulting services that focus on accelerating clinical trials, improving protocols, and optimizing procedures of clinical research. The Shamrock division of Speedus, on the other hand, specializes in drug development. They offer services in the area of drug development, clinical trials, and drug approval. Another important aspect of Speedus' business model is collaboration with partners and customers. For example, Speedus has agreed to collaborate with Quest Diagnostics, a leading company in the field of medical diagnostics. The agreement stipulates that Speedus will expand the Quest Diagnostic network by around 730 locations. This allows Quest customers nationwide to access their medical samples more quickly and efficiently. In addition to medical sample delivery services, Speedus Corp also offers a wide range of products, including devices and accessories designed to support companies in conducting clinical trials. This includes specialized sample containers and packaging that ensure the safe transportation of samples and contribute to reliable and meaningful results in clinical trials. In summary, Speedus Corp is an innovative and dynamic company that specializes in the field of medical services. With its wide range of services and products, the company is able to provide comprehensive support and advice to its customers, whether in the area of sample delivery, clinical trials, or drug development. Collaboration with partners and customers is a crucial part of Speedus Corp's success. Output: Speedus Corp is a US-American company specializing in medical services, including the delivery of medical samples, preparations, and instruments. It is divided into three divisions: Speedus, RTI, and Shamrock. Speedus offers courier services for the medical field, while RTI focuses on clinical research and development, and Shamrock specializes in drug development. Speedus collaborates with partners like Quest Diagnostics to expand their network. They also offer a range of products and support services for clinical trials. Overall, Speedus Corp is an innovative and dynamic company focused on providing comprehensive medical services. Speedus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Speedus stock

Accounts Receivable of Speedus is 55,000.00 USD in 2026.

On Eulerpool you can find the complete historical development of Accounts Receivable Speedus since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Speedus historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Speedus

All Key Metrics — Speedus